ArticleVeterinary medicine international2025
Single-Cell ICP-MS in Veterinary Research: Measuring Cisplatin Uptake in Healthy and Cancerous Animal Cell Lines.
Article in Veterinary medicine international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Single-Cell ICP-MS in Veterinary Research: Measuring Cisplatin Uptake in Healthy and Cancerous Animal Cell Lines.Veterinary medicine international · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Platinum derivatives have been used in cancer treatment for several decades. However, the clinical effectiveness of these drugs is significantly hindered by their toxicity, resulting from accumulation in healthy cells and by the development of resistance in specific cancer cells. Previous research has successfully explored cisplatin's mechanisms of cell transport, its antineoplastic effects, and its toxicity. Nevertheless, quantifying platinum uptake in individual cells posed a technological challenge until recent advancements. The single-cell inductively coupled plasma mass spectrometry (SC ICP-MS) method utilized in this study addresses this challenge. In our experiments, we used two murine carcinoma cell lines, C26 (colorectal carcinoma) and 4T1 (mammary carcinoma), along with a healthy epithelial cell line (MDCK) derived from a canine kidney. The cell cultures were exposed to various concentrations of cisplatin (10, 20, and 40 μM) for 24 h, followed by three washing steps and centrifugation. We monitored morphological changes in the cell cultures using an Olympus IX70 inverted phase-contrast microscope, while cell counts were measured with a Merck Scepter 3.0 cell counter. The uptake of platinum and its intercellular distribution were assessed using a PerkinElmer NexION2000 ICP-MS. Different cell lines absorbed platinum to varying degrees when exposed to the same cisplatin concentrations. Higher drug concentrations corresponded to increased amounts of platinum measured within all cell cultures. This relationship was directly proportional for several cell lines within specific concentration ranges. Notable cell death occurred in all cell line cultures when exposure exceeded a particular concentration, resulting in cell fragmentation. The SC ICP-MS technique detected this as an increase in cell number. Our findings corroborate several previous studies and highlight the applicability of the SC ICP-MS method in both human and animal cancer research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.